The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. - Wikidata - wikimedia - TriplyDB

The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report.

The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report.

http://www.wikidata.org/entity/Q33769989

about

Vitamin K: the effect on health beyond coagulation - an overview Nutritional strategies for skeletal and cardiovascular health: hard bones, soft arteries, rather than vice versa Proper Calcium Use: Vitamin K2 as a Promoter of Bone and Cardiovascular Health The health benefits of vitamin K Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein.Gla-rich protein is a potential new vitamin K target in cancer: evidences for a direct GRP-mineral interaction.High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trial Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients.A current understanding of vascular calcification in CKD.The molecular biology and pathophysiology of vascular calcification.Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.The relation between serum phosphorus levels and clinical outcomes after acute myocardial infarction Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults.Assessment of potential biomarkers of subclinical vitamin K deficiency in patients with end-stage kidney disease.High-Dose Menaquinone-7 Supplementation Reduces Cardiovascular Calcification in a Murine Model of Extraosseous Calcification.Phosphate binders affect vitamin K concentration by undesired binding, an in vitro study.Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study.Vitamin K Dependent Protection of Renal Function in Multi-ethnic Population Studies.Matrix Gla-Protein (MGP) Not Only Inhibits Calcification in Large Arteries But Also May Be Renoprotective: Connecting the Dots The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials Vitamin K status and vascular calcification: evidence from observational and clinical studies.The role of vitamin K in soft-tissue calcification.Vascular calcification in chronic kidney disease: Pathogenesis and clinical implication Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.Vitamin-K-Dependent Protection of the Renal Microvasculature: Histopathological Studies in Normal and Diseased Kidneys.Vitamin K status in chronic kidney disease.Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms.Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: an important but poorly studied relationship.Mechanisms and treatment of extraosseous calcification in chronic kidney disease.Osteoporosis--a risk factor for cardiovascular disease?Public health relevance of drug-nutrition interactions.The Cerebrovascular-Chronic Kidney Disease Connection: Perspectives and Mechanisms.The role of vitamin K in vascular calcification of patients with chronic kidney disease.Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells.Vitamin K-Dependent Protein Activity and Incident Ischemic Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis.A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma.The Role of Vitamin K Status in Cardiovascular Health: Evidence from Observational and Clinical Studies.Canola and hydrogenated soybean oils accelerate ectopic bone formation induced by implantation of bone morphogenetic protein in mice

P2860

Q24602306-E2056420-E9B7-423F-9826-33C338530900 Q26752732-5AFC6AE7-EB0A-4623-873B-164D76522D6F Q26771939-8F19748B-C52D-4F3D-BB06-D4A141D55051 Q26782816-F59F2A29-E70F-427A-8B08-B03E3ECD93E4 Q33595040-03D8C1FD-2CB3-485A-9919-120305BDA6C5 Q33737404-7D582BB5-C83F-4D9B-B4E6-41AF2245CE06 Q33776200-9BB34631-B9D6-4B3A-9549-E6672D03831E Q34241519-9210A26B-DF11-4739-9F43-1286769DACCB Q34355897-D21C8BAF-7FAF-489E-8A67-2280C40E0E6D Q34412941-1C96AF56-2697-4D2F-A96F-71F7ED82FC81 Q34464708-FACC0C38-7245-4705-8F7A-7A9DADF0E9D3 Q34534951-7031765E-B562-4C6D-9257-511C8917E7EF Q34625745-82FA2A6E-A6C2-4234-949F-8FA9CE7F618D Q35030652-1D143702-D367-4EBB-B827-4BE0D42650D7 Q35112095-88F7CBFA-3A94-4429-9F04-479E597A6C62 Q35147833-815CFBC7-0B6E-43ED-8C48-F06BBD4AE4AE Q35752060-770CD137-6DD6-46B3-AB43-957018A3E1B5 Q36361143-72B181F2-0460-4661-8C7A-1593D2D384C9 Q36538088-2ED29726-DF79-4D3E-9019-4E1845FA33EA Q36645022-7BBCF9C5-298C-475F-855F-BF6C08D6ECFC Q36645711-762EC71E-36A0-4C58-A2D6-D573A92B0B10 Q36689187-08B5EA0A-C5C5-47C1-81F2-ECBE620FB309 Q36828717-3E98ED45-33A7-45D3-B2C8-818FED77D9DA Q36828721-AA7AE01D-586E-4524-8701-16C197B6275D Q37195354-3FF38BB8-2014-4D52-8834-3688E32FEAA9 Q37278038-01C2AAB3-854D-4388-A624-3A83251AE49D Q37315160-AB427145-BE24-4E69-9501-45B0B1F2D2A2 Q37357929-5938F0B1-91D0-446C-ADEB-8A82CCBB5D69 Q37662635-6ABAD85B-E377-4837-AE30-6DD4881D99CA Q37810737-33617A80-5757-45DA-B2EC-FFA74818B9A0 Q37902504-8A22177C-4DBD-4706-B839-E56495321615 Q38034388-0B614E2C-3AC3-4100-8E9E-97A342E19201 Q38651214-E79FB4A1-D3AB-4911-A164-7433537F8C19 Q38821293-08E22B02-7324-4924-94E4-A25BE998ED83 Q38851700-7F9A615B-2173-474F-91B2-500866396BA6 Q39429146-78B76FA7-4538-42AB-B9B1-21D533BC2544 Q40823321-94EA348F-0484-4C7E-A538-CD8660D4C34E Q41191725-94E3F025-1CEC-4E4C-8169-D07608592578 Q41625344-68F8D3E0-FBF0-49E8-8FE3-2C0B12A887B7 Q41680932-85281310-A425-4B5A-83C7-F464E33DCF10

P2860

The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report.

http://www.wikidata.org/entity/Q33769989

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The circulating inactive form ...... disease: a preliminary report.

@ast

The circulating inactive form ...... disease: a preliminary report.

@en

type

label

The circulating inactive form ...... disease: a preliminary report.

@ast

The circulating inactive form ...... disease: a preliminary report.

@en

prefLabel

The circulating inactive form ...... disease: a preliminary report.

@ast

The circulating inactive form ...... disease: a preliminary report.

@en

P1433

Q33769989-9C3F950D-0901-496E-995C-9138F93E6AE3

P1476

Q33769989-224A7A3D-D8FF-454E-8211-05522FBA0159

P2093

Q33769989-079DD104-0648-438D-B374-E18414AADC55

Q33769989-0C8C1F36-5600-4D7A-976D-5D8B66FC60C1

Q33769989-5A98734B-7F0F-4F81-9490-78D693DDEF0A

Q33769989-75295300-0415-4ED5-9DC1-0808BC0AC213

Q33769989-7EE8C959-DB09-439C-805E-8518A9331284

Q33769989-91BD0102-A6D2-47B1-BAB6-3929164A400E

Q33769989-A83C685D-D813-4805-9740-223E8589FAAE

Q33769989-B8141D71-6FBD-4F9B-A761-8A7E39B2C6EE

P2860

Q33769989-05056AE4-9796-4199-857A-DAF69386018D

Q33769989-06D303E6-04F8-4463-BE71-8E7C061CB6A0

Q33769989-0D0D0F00-0ED1-47EB-8303-D707B82EEED9

Q33769989-251C43D7-5F91-4012-A4BA-E5B8F0646985

Q33769989-260ED290-4E26-481C-8D34-8459C3EA62BC

Q33769989-2CDB8ACA-0ADF-4131-86E3-C791969DE53B

Q33769989-40D9391F-5DC7-4FF2-BFB7-842A4ACFC7EF

Q33769989-46FD5762-4CD9-4556-AEDB-DF50ED331FB1

Q33769989-47A78AE1-827B-4847-8025-B0E8771318AC

Q33769989-4D6AD8DD-B3B7-48C5-8637-5B1D16FB4AC3

P304

Q33769989-44D1D556-1692-4199-913E-BBFD85A86B50

P31

Q33769989-8A702F36-5D12-4A5B-B3C2-77313B3EB8B3

P356

Q33769989-FA66B182-CCDD-40AB-A6D1-0869BC355A9B

P433

Q33769989-C6F008F8-61B5-4F0C-8330-7C5F472ECF9A

P478

Q33769989-C1FD9B12-2FF0-48CE-B294-6DA1099B61AD

P50

Q33769989-FD95849B-20A9-4BC9-859E-70C0DBB2EE08

P577

Q33769989-CDC43569-E062-41BD-98CF-B39771553D12

P5875

Q33769989-BBBAC848-B0ED-49EC-8E2A-741A78C2AD19

P698

Q33769989-54F1C700-E72E-4978-81E8-7907B1923C48

P932

Q33769989-DD4DBB13-69B1-499E-B3C0-FA5B4FC098A0

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

The circulating inactive form ...... disease: a preliminary report

@en

P2093

Cédric Renard

http://www.w3.org/2001/XMLSchema#string

Daniela V Barreto

http://www.w3.org/2001/XMLSchema#string

Elke J Magdeleyns

http://www.w3.org/2001/XMLSchema#string

Fellype C Barreto

http://www.w3.org/2001/XMLSchema#string

Gabriel Choukroun

http://www.w3.org/2001/XMLSchema#string

Leon J Schurgers

http://www.w3.org/2001/XMLSchema#string

Sophie Liabeuf

http://www.w3.org/2001/XMLSchema#string

Ziad A Massy

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Prediction of creatinine clearance from serum creatinine

Association of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study.

The clinical epidemiology of cardiac disease in chronic renal failure.

Oral anticoagulant treatment: friend or foe in cardiovascular disease?

Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study.

P304

568-575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.07081009

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41408341

http://www.w3.org/2001/XMLSchema#string

P698

20133489

http://www.w3.org/2001/XMLSchema#string

P932

2849687

http://www.w3.org/2001/XMLSchema#string